Lymphoma, T-Cell, Cutaneous

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

Active, not recruiting
  • Mycosis Fungoides
  • +2 more
  • Graz, Austria
  • +53 more
Dec 12, 2022

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

No longer available
  • Disease, Hodgkin
  • +3 more
  • brentuximab vedotin
  • Stanford, California
  • +30 more
Sep 17, 2020

Lymphoma, T-Cell, Cutaneous Trial in Worldwide (Quisinostat, 12 mg)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • Quisinostat, 12 mg
  • Pittsburgh, Pennsylvania
  • +12 more
Nov 2, 2016

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +34 more
Feb 29, 2008

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +33 more
Feb 29, 2008